StockData
GSKNYSEPharmaceutical PreparationsAlso trades as GLAXF

GSK plc

Financials through fiscal 2025, year ended Dec 31, 2025
$49.46−0.05 (-0.10%)

Close on Oct 19, 2026

GSK plc revenue by segment

No segment breakdown reported

GSK does not break out revenue by segment, region or product in the tagged data of its filings for this period type.